Clinical trial
G551D Observational Study (GOAL)-Expanded to Additional Genotypes and Extended for Long Term Follow up (GOAL-e2)
NCT01521338 is registered in ClinicalTrials.gov with Steven M Rowe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- G551D Observational Study (GOAL)-Expanded to Additional Genotypes and Extended for Long Term Follow up (GOAL-e2)
- Lead sponsor
- Steven M Rowe
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- June 30, 2021
- Enrollment
- 120 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.